MS4A1 encodes a B-lymphocyte surface molecule CD20 that has been reported to be associated with lipid metabolism and immune cell activation, and its expression is an independent predictor of cancer prognosis (Mudd et al., 2021; Li and Fang, 2022). The gene discussed is MS4A1; the disease is cancer.